NAQUA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Naqua, and what generic alternatives are available?
Naqua is a drug marketed by Schering and is included in one NDA.
The generic ingredient in NAQUA is trichlormethiazide. There is one drug master file entry for this compound. Additional details are available on the trichlormethiazide profile page.
Summary for NAQUA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 84 |
Patent Applications: | 3,748 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NAQUA at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NAQUA
US Patents and Regulatory Information for NAQUA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | NAQUA | trichlormethiazide | TABLET;ORAL | 012265-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | NAQUA | trichlormethiazide | TABLET;ORAL | 012265-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |